Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for December 2010
December 1, 2010
- Pfizer Move to Result in 186 Layoffs in Vonore
- Pfizer Move To Result In 186 Layoffs In Tennessee
- Malaysia Tests Vaccine As Dengue Fever Deaths Rise
- Novartis To Cut 1,400 Sales Positions From US Unit, Expects $85 Million Charge
- Endo Pharmaceuticals Successfully Completes Acquisition of Qualitest Pharmaceuticals for $1.2 Billion
- FDA and Life Sciences Industry Relationship Is Complicated By New Science and Changing Expectations, Finds PWC Survey
- Simcere Unit Gets New Fine Over Rabies Vaccine
December 2, 2010
- FDA Wants More Data on Valeant-Glaxo Epilepsy Drug
- Merck to Acquire SmartCells, Inc.
- Cubist Says FDA Approves Fast-Injection Cubicin
- People Warned To Be Wary Of Phone Scams
- Triad Lawyer Helps Win Suit Against Novartis
- FDA Panel Says Risks Of High-Grade Tumors With Merck Drug Outweigh Benefits
- FDA Wants More Data On Valeant-Glaxo Epilepsy Drug
- Momenta Pharmaceuticals Sues Teva for Patent Infringement
- Momenta Files Generic Lovenox Lawsuit Against Teva
December 3, 2010
- Novartis Clarifies Cost To Build Vaccine Plant
- Some Chemotherapy Drugs Scarce Here, Nationwide
- Pfizer Downplays Results From Resveratrol Drug
- Roche Chief Touts Skin-Cancer Drug
- Theft Of Pharmaceutical Waste For Meth From Sanofi Site Leads to 15-Year Sentence
- UM Prof Accused Of Submitting Ghostwritten Textbook
- Alnylam Says It Won Europe RNA Patent Dispute
- AstraZeneca Gets Recommendation On Cancer Drug
- State Intends to Renew Pfizer Wastewater Discharge Permit
- INTUNIV - Shire Files Suit Against Impax and Watson
- Halozyme Therapeutics Realigns Management
- More Than 1,000 Drug Patents Expiring During the Next Two Years: PharmaLive Special Reports
December 6, 2010
- Kindler Suddenly Leaves as Pfizer CEO
- FDA Delays Decision On Lupus Drug Benlysta
- Federal Report on Stent Procedures Finds Potential Fraud
- AstraZeneca Hit By EU Collusion Claims
- Orexigen Shares Tumble On FDA Review Of Contrave
- Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer
- Public believe China and India set to become World leaders for innovation, survey shows
- Public Believe China and India Set to Become World Leaders for Innovation, Survey Shows
- Elan Names Robert A. Ingram Chairman-Designate
December 7, 2010
- FDA Sends Allergan Letter for 'Misleading' Lumigan Direct Mail
- Elan Picks Drug Exec As Chairman
- Watson Enters Partnership For Generic Revlimid
- Blockbuster Drug Kicks Up A Legal Storm
- Pfizer At Crossroads As CEO Leaves
- Glaxo Expands In China With $70 Million Buy, but US Delays Lupus Drug Approval
- Analyst Upgrades Glaxo, Novartis, Downgrades AstraZeneca
- West Announces Plan to Consolidate Certain Operations
- More than 1,000 drug patents expiring during the next two years: PharmaLive Special Reports
December 8, 2010
- Bayer's Perspective on Innovation 2010
- Johnson & Johnson Launches Recommended Public Offer to Acquire Crucell
- Pharmaceutical Manufacturers to Pay $421.2 Million to Settle False Claims Act Cases
December 9, 2010
- Roche Provides Update on Leading Late-Stage Pharmaceutical Pipeline
- Texas Sued Over Sale of Baby Blood Samples to Pharma, Military
- Bayer Plans to Significantly Expand Capacities in China
- Active Biotech, Teva Unveil Positive Phase III Results For MS Drug
- Generic Flonase Sales Boost Hi-Tech's 2Q Profit
- Caliper Buying Cambridge Research For $20 Million
- Analyst: FDA Decision Poses Risk for AstraZeneca
- J&J Must Pay $1.7 Million in Levaquin Case
December 10, 2010
- FDA Issues Guidance on Public Comment Procedures at Advisory Committee Meetings
- Nigeria: Pfizer Sought Dirt on Nigerian Official
- Eisai Marks Fully-fledged Entry into Japanese Oncology Market with Launch of Anticancer Agent Treakisym Injection 100 MG
- Pfizer Stops Clinical Trials of Thelin and Initiates Voluntary Product Withdrawal in the Interest of Patient Safety
- Inquiry Into Troubled Drug Study Urged At University of Minnesota
- Bone Drug Zometa Does Not Help Most With Early Or Mid-Stage Breast Cancer: Study
- Thelin (sitaxentan) to be withdrawn due to cases of unpredictable serious liver injury
- European Medicines Agency to review the safety of somatropin-containing medicines
- FDA Sends Watson Letter Over Gelnique Promotion
- Cable Reveals Pfizer Sought Dirt on Nigerian Official
December 13, 2010
- Not All Placebos Are Born Equal
- Pfizer Tops the List As Big Pharma Turns to Acquisitions As Its Preferred Growth Track
- Va. Governor Mcdonnell Announces 190 New Jobs In Henrico County
- Amgen, Actelion Discuss Potential Offer
- Merck KGaA: Changes in the Executive Board
- Unigene to Advance Phase 2 Development of Oral PTH Program by Entering into an Amended and Restated Exclusive Worldwide License Agreement with GSK
- Valeant Says Chairman Bill Wells Has Resigned
- Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
- BrainStorm Announces Resignation of CEO and Appointment of Former Consul General of Israel in New York, Ambassador Alon Pinkas, to the Board of Directors
- Genzyme Reiterates Board's Position on Sanofi-Aventis Tender Offer
- Anaphore Enters R&D Partnership with Mitsubishi Tanabe Pharma to Develop and Commercialize Novel Protein Pharmaceuticals for Autoimmune Disorders
December 14, 2010
- Lilly Suspends Phase III Trial in Metastatic Melanoma
- Lundbeck Will Substantially Increase Sales and Marketing Efforts Behind Lexapro in China
- Talecris Biotherapeutics Announces Jury Verdict in Contract Dispute
- Amgen Touts New Trial Of Bone-Strengthening Drug
- Pfizer Board of Directors Elects George A. Lorch Non-Executive Chairman
- Deloitte Report: 65 Percent of Life Sciences Company Professionals Use/Plan to Use Social Networking
- Sanofi-Aventis Appoints Dr. Elias Zerhouni, President, Global Research & Development
- Former Merck Exec Becomes Bausch & Lomb?s Corporate VP & Global President, Pharma Business: PharmaLive Special Reports
- Healthcare Industry Now Offering Improved Diagnoses, Earlier Interventions, and Better Medical Outcomes with Personalized Medicine
- 36 Million Americans have Bought Medications Online Without a Doctor's Prescription
- Everyday Health, Inc., Enters Into Healthcare Professional Market with Acquisition of MedPage Today, LLC
December 15, 2010
- Alcon and Novartis Agree to Merger Terms
- Tranzyme Pharma Appoints Pharmaceutical Industry Veteran John H. Johnson as Chairman of its Board of Directors
- Policies On Drug-Firm Gifts Eyed
- Ipsen Closes its BIM 23A760 Trials
- Adimab Announces New Discovery Programs with Eli Lilly, Genentech and Human Genome Sciences
- Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee
- UCB optimizes its manufacturing network
- Novartis Seals Alcon Takeover After Cash Deal With Minority Shareholders
- Advanced Cell Technology Mourns the Passing of its Chairman and CEO William M. Caldwell IV
- RoundTable Healthcare Partners Announces Sale of Clinical Innovations, LLC to The Pritzker Group
- Glaxo Set to Re-Start Share Buyback
December 16, 2010
- Pfizer Extends Tender Offer for King
- Elan to Pay $203 Million in Zonegran Case
- ARYx Therapeutics Provides Update on Company Status
- Genentech Provides Update on Avastin for Metastatic Breast Cancer Following Reviews in Europe and the United States
- FDA Begins Process to Remove Breast Cancer Indication from Avastin Label
December 17, 2010
- Thousands On HIV Drugs Desperate Amid Budget Woes
- Merck KGaA and sanofi-aventis Sign Agreement to Jointly Investigate Novel Combinations Against Cancer
- Department of Justice Declines to Intervene in Lawsuit against Gilead Sciences Regarding Ranexa
- AstraZeneca Drops Nearly 5% After US Fails to Approve Brilinta drug
- Amarin Recruits 700 Patients to Test Heart Drug
- Dr. Reddy's to Add Positions
- European Medicines Agency Recommends Action Plan to Deal With Possible Presence of Endotoxins in Baxter Peritoneal Dialysis Solutions
December 20, 2010
- FDA Drug Safety Communication: Abnormal Heart Rhythms Associated with Use of Anzemet (dolasetron mesylate)
- Sanofi-aventis and Avila Therapeutics Sign Global Alliance to Develop Targeted Covalent Oncology Drugs
- Bristol-Myers Squibb and Oncolys BioPharma Enter Global Licensing Agreement for Investigational HIV Compound
- Novartis To Invest $500 Million In Russia
- Gilead Sciences to Acquire Arresto Biosciences for $225 Million
- Copaxone Market Share Drops in November
- Report On Fraud A Bitter Pill For Pfizer, GlaxoSmithKline
- Novartis Affirms Commitment to Russia Through USD 500 Million Multi-Year Healthcare Investment
- Lpath Grants Pfizer Exclusive Option for Worldwide License for iSONEP
December 21, 2010
- Dey Pharma Settles Federal Pricing Case
- Biogen Idec and Neurimmune Announce Agreement on Three Neurodegenerative Disease Programs
- Proximagen Acquires Two CNS Drug Development Programmes From Glaxosmithkline
- Epicept Says Leukemia Drug Approved In Israel
- Lilly Alzheimer's Imaging Agent To Get FDA Review
- AstraZeneca Drops Work On Respiratory Drug Motavizumab
- Man Gets Jail for Bilking Drug Firms
- Biogen Idec In $427M Deal With Neurimmune
- Vivus Asks For Weight-Loss Drug Approval In Europe
- 'What the UK Is Doing Is the Envy of People in Washington'
- Lilly Announces Completion of Avid Acquisition and FDA Priority Review for Florbetapir
- AstraZeneca Discontinues Development of Motavizumab for RSV Prophylaxis Indication
- Safeguard Scientifics to Realize at Least $36 Million in Initial Sale Proceeds from Eli Lilly's Completed Acquisition of Partner Company Avid Radiopharmaceuticals
December 22, 2010
- New Study Finds Pharmacists and Nurses are the Most Effective in Promoting Medication Adherence
- Clavis Pharma's elacytarabine granted FDA Fast Track designation in USA
- PhRMA Elects Four New Members to Board of Directors
- Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving Actos (pioglitazone HCI), ACTOplus met (pioglitazone HCl and metformin HCl) and duetact(R) (pioglitazone HCl and glimepiride)
- Pfizer Recalling More Lipitor Bottles
- Dozen Stanford Physicians Under Fire For Speaking At Gigs Paid For By Drug Makers
- Merck To Pay $280 Million Dey Settlement
- Top 20 Pharma's R&D Spending Topped $86 billion in 2009
- Gilead Terminates Phase III Clinical Trial of Ambrisentan in Patients with Idiopathic Pulmonary Fibrosis
December 23, 2010
- Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
- Novartis Will Add Lab And 100 Jobs In North Carolina
- AstraZeneca, Abbott End Cholesterol Drug Effort
- Amylin And Lilly Seek Expanded Byetta Approval
- FDA Expands Approval Of HPV Vaccine Gardasil
December 26, 2010
- Glaxo Offers NHS Rebate If Latest Cancer Drug Fails To Outperform Pfizer's Rival
- Teva Says FDA Won't Approve New Version Of MS Drug
December 27, 2010
- ARYx Therapeutics Clarifies Current Status of Operations
- American Regent Initiates Nationwide Voluntary Recall of Sodium Bicarbonate Injection, USP 7.5% and 8.4%, 50 mL Single Dose Vials Due to Particulate Matter
December 28, 2010
- Regeneron, Sanofi-Aventis Put Drug Study on Hold
- K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission
- Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
- ReSearch Pharmaceutical Services to be Acquired by Warburg Pincus
- ActivBiotics Pharma, LLC Terminates its Association with Triobiotics Pharma AG
- Biosante Raises $16.9M By Selling Stock, Warrants
- Dishman In Pact With European MNC For Cardiac Drug
- FDA Halts J&J Study Of Pain Drug Over Safety
December 29, 2010
- Cardiome Provides Update for Oral Vernakalant Development Program
- Savient Pharmaceuticals Announces Search for CEO
- Sucampo Pharmaceuticals, Inc. Acquires Sucampo AG to Strengthen Its Prostone Intellectual Property Portfolio
